Search Results 31-40 of 17174 for ibs

  1. Fecal Microbiota Transplantation for IBS - Mayo Clinic

    ... irritable bowel syndrome (PI-IBS) and high proteolytic activity. Proteolytic activity is the breakdown of proteins into smaller polypeptides or amino acids ...

  2. Research using latent class analysis reveals distinct patient clusters based on clinical, dietary, lifestyle and psychosocial factors associated with IBS

    The seven unique disease subsets identified among patients diagnosed with irritable bowel syndrome (IBS) suggest that variables beyond predominant bowel ...

  3. Understanding the role of proteolytic activity in mediating irritable bowel syndrome symptoms and disruption of intestinal barrier function - Mayo Clinic

    Elevated PA levels have been observed in fecal and tissue supernatants from patients with diarrhea and constipation-predominant irritable bowel syndrome (IBS-C) ...

  4. Alosetron (oral route) - Mayo Clinic

    Description. Alosetron is used to treat irritable bowel syndrome (IBS) in women who have diarrhea as their main symptom. This medicine is only used in ...

  5. Study of the Research Medicine CIN-103 in Adults With Irritable Bowel Syndrome With Predominant Diarrhea (IBS-D). - Mayo Clinic

    Study of the Research Medicine CIN-103 in Adults With Irritable Bowel Syndrome With Predominant Diarrhea (IBS-D). · Overview · Participation eligibility.

  6. Mayo Clinic Radio: Irritable bowel syndrome

    Signs and symptoms can include cramping, abdominal pain, bloating, gas and a change in bowel habits. While IBS is a chronic condition, many people can control ...

  7. Irritable Bowel Syndrome is Not "All in the Head"

    That way, we can foster individualized, specific treatment for patients with IBS." Click here for new release. Sound bites are available in the downloads above.

  8. A Study Using Biomerica InFoods® IBS Test in Patients with Irritable Bowel Syndrome (IBS) - Mayo Clinic

    The purposes of this study are to to evaluate the use of IgG antibody guided dietary restrictions, based on the Biomerica InFoods® IBS ELISA, in the management ...

  9. An updated appraisal of the SIBO hypothesis and the limits of breath testing - Mayo Clinic

    ... irritable bowel syndrome (IBS) and other disorders of the gut-brain interaction (DGBI). The SIBO-IBS hypothesis prompted important research examining the ...

  10. Comparison of Rimegepant and Placebo for Pain in IBS - Mayo Clinic

    The primary aim of this study is to evaluate the efficacy of rimegepant on abdominal pain scores in participants with non-constipation IBS. Participation ...